Liehao Jiang

611 total citations
27 papers, 430 citations indexed

About

Liehao Jiang is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Liehao Jiang has authored 27 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Oncology. Recurrent topics in Liehao Jiang's work include Thyroid Cancer Diagnosis and Treatment (14 papers), Ferroptosis and cancer prognosis (5 papers) and RNA modifications and cancer (5 papers). Liehao Jiang is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (14 papers), Ferroptosis and cancer prognosis (5 papers) and RNA modifications and cancer (5 papers). Liehao Jiang collaborates with scholars based in China, Spain and United States. Liehao Jiang's co-authors include Minghua Ge, Zhuo Tan, Jun Cao, Jiafeng Wang, Chao Chen, Xin Zhu, Zhi‐Qiang Ling, Chuanming Zheng, Minghua Ge and Xiaoxiao Lu and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Advanced Science.

In The Last Decade

Liehao Jiang

24 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liehao Jiang China 12 194 151 125 103 80 27 430
Jingtai Zhi China 13 231 1.2× 163 1.1× 77 0.6× 65 0.6× 102 1.3× 29 443
Xinwei Yun China 11 345 1.8× 133 0.9× 147 1.2× 56 0.5× 99 1.2× 21 509
Minghua Ge China 9 148 0.8× 135 0.9× 56 0.4× 40 0.4× 62 0.8× 27 329
Linfei Hu China 13 268 1.4× 109 0.7× 119 1.0× 23 0.2× 104 1.3× 34 451
Athanasios Bikas United States 11 120 0.6× 180 1.2× 74 0.6× 53 0.5× 97 1.2× 21 325
Juyong Liang China 10 195 1.0× 54 0.4× 88 0.7× 36 0.3× 110 1.4× 17 371
Kelli Gaskins United States 8 206 1.1× 66 0.4× 100 0.8× 56 0.5× 106 1.3× 9 340
Hamza Chettouh France 6 233 1.2× 33 0.2× 112 0.9× 74 0.7× 82 1.0× 7 421
Ranran Shi China 11 125 0.6× 33 0.2× 68 0.5× 43 0.4× 71 0.9× 25 302

Countries citing papers authored by Liehao Jiang

Since Specialization
Citations

This map shows the geographic impact of Liehao Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liehao Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liehao Jiang more than expected).

Fields of papers citing papers by Liehao Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liehao Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liehao Jiang. The network helps show where Liehao Jiang may publish in the future.

Co-authorship network of co-authors of Liehao Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Liehao Jiang. A scholar is included among the top collaborators of Liehao Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liehao Jiang. Liehao Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Juyong, et al.. (2025). The endoplasmic reticulum stress-ferroptosis reciprocal signaling orchestrates anti-tumor effect of anlotinib in anaplastic thyroid cancer. Cancer Cell International. 25(1). 310–310. 1 indexed citations
2.
Feng, Dongdong, Dongxue Hu, Fangfang Xu, et al.. (2025). Expression of membrane-bound Interleukin-15 sustains the growth and survival of CAR-NK cells. International Immunopharmacology. 166. 115577–115577.
3.
Cai, Yefeng, Yawen Guo, Pu Cheng, et al.. (2025). A new broom sweeps clean: CLDN16 surpasses the BRAF-V600E mutation as an unrivaled biomarker in papillary thyroid cancer. European Journal of Endocrinology. 192(2). 128–140.
4.
Zhang, Lizhuo, Qingqing Feng, Chuanming Zheng, et al.. (2025). Antigen‐Targeting Inserted Nanomicelles Guide Pre‐Existing Immunity to Kill Head and Neck Cancer. Advanced Science. 12(18). e2410629–e2410629. 2 indexed citations
5.
Liang, Juyong, Ruiqi Liu, Liehao Jiang, et al.. (2023). Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer. Endocrine Related Cancer. 30(9). 19 indexed citations
6.
Feng, Dongdong, et al.. (2023). Integrated proteomic and metabolomic analysis of plasma reveals regulatory pathways and key elements in thyroid cancer. Molecular Omics. 19(10). 800–809. 10 indexed citations
8.
Liu, Yujia, Jiafeng Wang, Xiao Hu, et al.. (2023). Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy. Drug Resistance Updates. 68. 100939–100939. 39 indexed citations
9.
Ma, Wenli, Zhuo Tan, Liehao Jiang, et al.. (2023). Level II lateral neck dissection for papillary thyroid carcinoma: A retrospective cohort study. Asian Journal of Surgery. 46(10). 4290–4295. 4 indexed citations
10.
Pan, Zongfu, Xiao Hu, Tiefeng Jin, et al.. (2022). CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment. Molecular Cancer. 21(1). 190–190. 68 indexed citations
11.
Xu, Jiajie, Yunfeng Liu, Chuanming Zheng, et al.. (2022). Novel computer-aided reconstruction of soft tissue defects following resection of oral and oropharyngeal squamous cell carcinoma. World Journal of Surgical Oncology. 20(1). 196–196. 5 indexed citations
12.
Zhou, Zheng, et al.. (2022). A Systematic Pan-Cancer Analysis of CASP3 as a Potential Target for Immunotherapy. Frontiers in Molecular Biosciences. 9. 776808–776808. 25 indexed citations
13.
Fang, Luo, Yiwen Zhang, Zongfu Pan, et al.. (2021). Comparison of Proteomics Profiles Between Xenografts Derived from Cell Lines and Primary Tumors of Thyroid Carcinoma. Journal of Cancer. 12(7). 1978–1989. 3 indexed citations
14.
Jiang, Liehao, et al.. (2021). Advances in targeted therapy for anaplastic thyroid carcinoma. Journal of Zhejiang University (Medical Sciences). 50(6). 685–693. 1 indexed citations
15.
Jiang, Liehao, et al.. (2020). Predictive Risk-scoring Model For Central Lymph Node Metastasis and Predictors of Recurrence in Papillary Thyroid Carcinoma. Scientific Reports. 10(1). 710–710. 42 indexed citations
16.
Jiang, Liehao, Minghua Ge, Jun Cao, et al.. (2015). miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma. Laboratory Investigation. 95(12). 1398–1408. 47 indexed citations
17.
Jiang, Liehao, et al.. (2015). Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter. Clinical Laboratory. 61(07/2015). 793–9. 8 indexed citations
18.
Zhu, Xin, Jianguo Feng, Liehao Jiang, et al.. (2014). Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma. Journal of Experimental & Clinical Cancer Research. 33(1). 114–114. 21 indexed citations
19.
Xu, Xiaoling, Weihui Zheng, Xianxing Li, et al.. (2014). Topo2A as a prognostic biomarker for patients with resectable esophageal squamous cell carcinomas. Medical Oncology. 32(1). 396–396. 11 indexed citations
20.
Jiang, Liehao, Chao Chen, Zhuo Tan, et al.. (2014). Clinical Characteristics Related to Central Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma: A Retrospective Study of 916 Patients. International Journal of Endocrinology. 2014. 1–6. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026